A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance
To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance. Cross-over study of patients randomly assigned to a sequence of enalapril 20 mg once daily or 10 mg twice daily in three 4-week periods following a 4-week placebo run-in. General...
Saved in:
Published in: | Journal of hypertension Vol. 17; no. 11; pp. 1627 - 1631 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Hagerstown, MD
Lippincott Williams & Wilkins
01-11-1999
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance.
Cross-over study of patients randomly assigned to a sequence of enalapril 20 mg once daily or 10 mg twice daily in three 4-week periods following a 4-week placebo run-in.
General practices in the greater Belfast and Lisburn area in Northern Ireland.
Twenty-five hypertensive patients who had a mean diastolic blood pressure of between 90 and 110 mm Hg after receiving placebo for 4 weeks.
Reduction in blood pressure and estimation of patient compliance.
Patient compliance was superior on the once daily regimen. However, the twice daily regimen was associated with a greater blood pressure reduction which almost reached statistical significance at the 5% level.
Enalapril 20 mg should be prescribed as 10 mg twice daily and measures taken to improve patient compliance. |
---|---|
AbstractList | To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance.
Cross-over study of patients randomly assigned to a sequence of enalapril 20 mg once daily or 10 mg twice daily in three 4-week periods following a 4-week placebo run-in.
General practices in the greater Belfast and Lisburn area in Northern Ireland.
Twenty-five hypertensive patients who had a mean diastolic blood pressure of between 90 and 110 mm Hg after receiving placebo for 4 weeks.
Reduction in blood pressure and estimation of patient compliance.
Patient compliance was superior on the once daily regimen. However, the twice daily regimen was associated with a greater blood pressure reduction which almost reached statistical significance at the 5% level.
Enalapril 20 mg should be prescribed as 10 mg twice daily and measures taken to improve patient compliance. OBJECTIVETo compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance.DESIGNCross-over study of patients randomly assigned to a sequence of enalapril 20 mg once daily or 10 mg twice daily in three 4-week periods following a 4-week placebo run-in.SETTINGGeneral practices in the greater Belfast and Lisburn area in Northern Ireland.PATIENTSTwenty-five hypertensive patients who had a mean diastolic blood pressure of between 90 and 110 mm Hg after receiving placebo for 4 weeks.MAIN OUTCOME MEASURESReduction in blood pressure and estimation of patient compliance.RESULTSPatient compliance was superior on the once daily regimen. However, the twice daily regimen was associated with a greater blood pressure reduction which almost reached statistical significance at the 5% level.CONCLUSIONSEnalapril 20 mg should be prescribed as 10 mg twice daily and measures taken to improve patient compliance. |
Author | MCDERMOTT, B. J GIRVIN, B JOHNSTON, G. D |
Author_xml | – sequence: 1 givenname: B surname: GIRVIN fullname: GIRVIN, B organization: Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Whitla Medical Building, Belfast, United Kingdom – sequence: 2 givenname: B. J surname: MCDERMOTT fullname: MCDERMOTT, B. J organization: Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Whitla Medical Building, Belfast, United Kingdom – sequence: 3 givenname: G. D surname: JOHNSTON fullname: JOHNSTON, G. D organization: Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Whitla Medical Building, Belfast, United Kingdom |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1289801$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10608477$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkE1PxCAURYnR6Dj6FwwL464KhRZYTiZ-JSZudN1Q-maCoTBCq3Hjb5f5cJQNyeXc98g5RYc-eEAIU3JNiRI3JB8uRVlQpRQVlJIiJ1QcoAnlghVVpeQhmpCyZkXNqvIEnab0lhGpBDtGJ5TURHIhJuh7hk3oVzraFDwOCwxeO72K1uGS4H6JgzeAO23dF_6AmMaUP7HOh0-7f7AeDxD7tO63LoQOryKkNEbALnxCtH6Jtc-pHiz4YbPRWZ0nn6GjhXYJznf3FL3e3b7MH4qn5_vH-eypMIyToRBacF0qLqq6g451wLmRTBnBFQcJzPCuIlSLsuK8rVjbKc1aJWjb1mCIoGyKrrZzVzG8j5CGprfJgHPaQxhTUysmCFFlBuUWNDGkFGHRZBe9jl8NJc3affPrvtm7bzbuc_Vit2Nse-j-FbeyM3C5A3Qy2i1iNmDTH1dKJQllP7Lvjgg |
CODEN | JOHYD3 |
CitedBy_id | crossref_primary_10_1046_j_1365_2125_2002_01629_x crossref_primary_10_1002_14651858_CD000011_pub4 crossref_primary_10_1016_j_pec_2008_08_019 crossref_primary_10_1002_14651858_CD000011_pub3 crossref_primary_10_1016_j_ijnurstu_2006_07_010 crossref_primary_10_1186_1471_2377_7_20 crossref_primary_10_1097_JCN_0b013e3181d5f9c5 crossref_primary_10_1097_HJH_0b013e32832d50ef crossref_primary_10_1371_journal_pone_0243371 crossref_primary_10_1016_j_jclinepi_2007_04_007 crossref_primary_10_1111_jch_13011 crossref_primary_10_7759_cureus_17331 crossref_primary_10_1002_14651858_CD005182_pub4 crossref_primary_10_1016_j_amepre_2022_02_019 crossref_primary_10_1007_s11906_001_0009_7 crossref_primary_10_1016_S1138_3593_09_72673_5 crossref_primary_10_2147_vhrm_1_1_9_58940 crossref_primary_10_1038_ajh_2009_207 crossref_primary_10_1097_00004872_200410000_00002 crossref_primary_10_1186_s12936_015_0645_z crossref_primary_10_1157_13119915 crossref_primary_10_1080_08870446_2016_1273356 crossref_primary_10_1345_aph_1D268 crossref_primary_10_1007_s11606_019_05269_z crossref_primary_10_1016_S1134_2072_01_75471_0 crossref_primary_10_1002_14651858_CD004804 crossref_primary_10_1177_009286150403800213 crossref_primary_10_4037_ccn2007_27_6_62 crossref_primary_10_1016_j_ahj_2005_01_047 crossref_primary_10_1016_S0149_2918_04_80145_0 crossref_primary_10_1093_qjmed_hci139 |
Cites_doi | 10.1016/0140-6736(90)90944-Z 10.1038/clpt.1983.198 10.2307/2530762 10.1161/01.HYP.15.3.301 10.1001/archinte.150.9.1881 10.1038/clpt.1982.125 10.1097/00004872-199007000-00004 10.1097/00004872-199012000-00003 10.1007/BF00193697 10.1097/00004872-199412001-00014 10.1111/j.1600-0773.1990.tb00847.x 10.1038/clpt.1983.101 10.1136/hrt.60.3.177 |
ContentType | Journal Article |
Copyright | 2000 INIST-CNRS |
Copyright_xml | – notice: 2000 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1097/00004872-199917110-00017 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-5598 |
EndPage | 1631 |
ExternalDocumentID | 10_1097_00004872_199917110_00017 10608477 1289801 |
Genre | Comparative Study Clinical Trial Randomized Controlled Trial Journal Article |
GroupedDBID | --- .-D .55 .GJ .XZ .Z2 01R 08R 0R~ 1J1 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAXR AAGIX AAHPQ AAJCS AAMOA AAMTA AAQKA AARTV AASOK AAWTL AAXQO AAYEP ABASU ABBUW ABDIG ABFLS ABOCM ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACWDW ACWRI ACXNZ ADFPA ADGIM ADNKB AE3 AE6 AEBDS AENEX AFDTB AFFNX AFUWQ AGINI AHRYX AHVBC AI. AIJEX AJIOK AJNYG AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AWKKM BOYCO BQLVK BS7 C45 CAG COF CS3 DIWNM DU5 DUNZO E.X EBS EJD EX3 F2K F2L F2M F2N F5P FL- FW0 GQDEL H0~ HZ~ IKREB IKYAY IN~ IPNFZ IQODW JF9 JG8 JK3 JK8 K8S KD2 KMI L-C L7B N9A N~7 N~B N~M O9- OAG OAH OCUKA ODA ODMTH OHYEH OJAPA OL1 OLG OLH OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RIG RLZ S4R S4S T8P TEORI TSPGW V2I VH1 VVN W3M WOQ WOW X3V X3W X7M XXN XYM YFH YYP ZA5 ZFV ZGI ZXP ZZMQN AAAAV AAIQE AASCR AAUEB ABJNI ABVCZ ACILI ACLDA ACXJB ADGGA ADHPY AEETU AFEXH AFSOK AHOMT AHQNM AINUH AJNWD AJZMW AMNEI AOHHW CGR CUY CVF ECM EEVPB EIF ERAAH FCALG GNXGY HLJTE NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c340t-7a74a294756ded3de44c839c7494e8e3c4d501a72544b53bd9a3b971bb6ec0713 |
ISSN | 0263-6352 |
IngestDate | Fri Aug 16 21:57:16 EDT 2024 Thu Nov 21 21:08:02 EST 2024 Wed Oct 16 00:50:31 EDT 2024 Fri Nov 25 01:09:54 EST 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Human Hypertension Enzyme Single dose Enzyme inhibitor Cardiovascular disease Multiple dose Drug compliance Peptidases Chemotherapy Treatment Enalapril Peptidyl-dipeptidase A Hydrolases Peptidyl-dipeptidases Antihypertensive agent Arterial pressure |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c340t-7a74a294756ded3de44c839c7494e8e3c4d501a72544b53bd9a3b971bb6ec0713 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-News-3 content type line 23 |
PMID | 10608477 |
PQID | 69370092 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_69370092 crossref_primary_10_1097_00004872_199917110_00017 pubmed_primary_10608477 pascalfrancis_primary_1289801 |
PublicationCentury | 1900 |
PublicationDate | 1999-11-01 |
PublicationDateYYYYMMDD | 1999-11-01 |
PublicationDate_xml | – month: 11 year: 1999 text: 1999-11-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: England |
PublicationTitle | Journal of hypertension |
PublicationTitleAlternate | J Hypertens |
PublicationYear | 1999 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | (R12-17-20110409) 1990; 67 Ferguson (R5-17-20110409) 1982; 32 Collins (R16-17-20110409) 1991; 335 Saris (R2-17-20110409) 1983; 31 Detry (R9-17-20110409) 1995; 47 Ebbutt (R13-17-20110409) 1984; 40 Evans (R15-17-20110409) 1988; 60 Eisen (R17-17-20110409) 1990; 150 Chrysant (R6-17-20110409) 1983; 33 Meredith (R7-17-20110409) 1990; 8 Donnelly (R8-17-20110409) 1990; 15 Waeber (R10-17-20110409) 1994; 12 Simon (R3-17-20110409) 1983; 34 McMahon (R4-17-20110409) 1986; 40 OBrien (R14-17-20110409) 1990; 8 |
References_xml | – volume: 40 start-page: 114 year: 1986 ident: R4-17-20110409 publication-title: Cur Ther Res contributor: fullname: McMahon – volume: 31 start-page: 334A year: 1983 ident: R2-17-20110409 publication-title: Clin Res contributor: fullname: Saris – volume: 335 start-page: 827 year: 1991 ident: R16-17-20110409 publication-title: Lancet doi: 10.1016/0140-6736(90)90944-Z contributor: fullname: Collins – volume: 34 start-page: 459 year: 1983 ident: R3-17-20110409 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.1983.198 contributor: fullname: Simon – volume: 40 start-page: 219 year: 1984 ident: R13-17-20110409 publication-title: Biometrics doi: 10.2307/2530762 contributor: fullname: Ebbutt – volume: 15 start-page: 301 year: 1990 ident: R8-17-20110409 publication-title: Hypertension doi: 10.1161/01.HYP.15.3.301 contributor: fullname: Donnelly – volume: 150 start-page: 1881 year: 1990 ident: R17-17-20110409 publication-title: Arch Intern Med doi: 10.1001/archinte.150.9.1881 contributor: fullname: Eisen – volume: 32 start-page: 48 year: 1982 ident: R5-17-20110409 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.1982.125 contributor: fullname: Ferguson – volume: 8 start-page: 607 year: 1990 ident: R14-17-20110409 publication-title: J Hypertens doi: 10.1097/00004872-199007000-00004 contributor: fullname: OBrien – volume: 8 start-page: 1085 year: 1990 ident: R7-17-20110409 publication-title: J Hypertens doi: 10.1097/00004872-199012000-00003 contributor: fullname: Meredith – volume: 47 start-page: 477 year: 1995 ident: R9-17-20110409 publication-title: Eur J Clin Pharmacol doi: 10.1007/BF00193697 contributor: fullname: Detry – volume: 12 start-page: S67 year: 1994 ident: R10-17-20110409 publication-title: J Hypertens doi: 10.1097/00004872-199412001-00014 contributor: fullname: Waeber – volume: 67 start-page: 361 year: 1990 ident: R12-17-20110409 publication-title: Pharmacol Toxicol doi: 10.1111/j.1600-0773.1990.tb00847.x – volume: 33 start-page: 741 year: 1983 ident: R6-17-20110409 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.1983.101 contributor: fullname: Chrysant – volume: 60 start-page: 177 year: 1988 ident: R15-17-20110409 publication-title: Br Heart J doi: 10.1136/hrt.60.3.177 contributor: fullname: Evans |
SSID | ssj0008973 |
Score | 1.8534048 |
Snippet | To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance.
Cross-over study of patients randomly... OBJECTIVETo compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance.DESIGNCross-over study of... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 1627 |
SubjectTerms | Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive agents Biological and medical sciences Blood Pressure - drug effects Blood Pressure Monitoring, Ambulatory Cardiovascular system Cross-Over Studies Drug Administration Schedule Enalapril - administration & dosage Enalapril - therapeutic use Humans Hypertension - drug therapy Hypertension - physiopathology Medical sciences Patient Compliance Pharmacology. Drug treatments Posture - physiology |
Title | A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance |
URI | https://www.ncbi.nlm.nih.gov/pubmed/10608477 https://search.proquest.com/docview/69370092 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELa2WwkhIcSbBQo-cIsiJbbjx3Ep21JpKQe2Um9RYnvbldrsah_qjd_O2HEeK4qAA5doNZHjaOfzZMb-Zgahj4LpObXKxoJyHTNiTSwzxmMOUkOJ1SX3TWy_i_NL-XnCJoPBXRP1t7L_qmmQga5d5uw_aLt9KAjgN-gcrqB1uP6V3seBVh5aC0YWRhSr9eImIkl0exW5NMXIFG5XwzEydpso9fLt3aK94biPYLE9y8Mz2yNPl3VnDTeuq1qT2BiKsgZeeoufX33da4h2154r3536ny7AStXN4ntb1TBtoJB86k6sfBuvwPM_DRxlE1L3VEjZ6wwa4TQGB2ff-oo-ytKeLU15XTUgfJfBcUzvtfl1LWEf7EhBHHMGQtA09Qnz4el7ZbbPv-UnF9NpPptczg7QIQELxYbocHx8Nj1rP-JS1eSE5pUDCayp93nfTHuezaNVsYFFNq-7o_w-fPFuzOwJehx0gsc1cJ6iga2eoQdfA8PiOfoxxh1-8HKOW_xgkuDbK-zwgz1McI0feGMn9_gJNxYV9vhx4z1-cIMf3OAHA35wwA_u8PMCXZxMZsdf4tCjI9aUJdtYFIIVRDGRcQOL21jGNPjcWjDFrLRUM5MlaSFcJbwyo6VRBS2VSMuSW-12SF6iYbWs7GuEqSxhpDLKmIzNiZBynnFJtTAF1RBZjFDa_L_5qi7FkvcoFF4neasTz6oQI3S0p4huIJEKnLMR-tAoJge76g7Lisoud5ucg9_uCpKN0KtaX705eQI-nXjzx7Fv0cNuHbxDw-16Z4_Qwcbs3ge8_QSZf5oG |
link.rule.ids | 315,782,786,27934,27935 |
linkProvider | Ovid |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+comparison+of+enalapril+20+mg+once+daily+versus+10+mg+twice+daily+in+terms+of+blood+pressure+lowering+and+patient+compliance&rft.jtitle=Journal+of+hypertension&rft.au=Girvin%2C+B&rft.au=McDermott%2C+B+J&rft.au=Johnston%2C+G+D&rft.date=1999-11-01&rft.issn=0263-6352&rft.volume=17&rft.issue=11&rft.spage=1627&rft.epage=1631&rft_id=info:doi/10.1097%2F00004872-199917110-00017&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0263-6352&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0263-6352&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0263-6352&client=summon |